Principal Investigators

Clinical Genetics Branch (CGB)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

C

  • Clarke, Megan A., Ph.D., M.H.S.
    Dr. Clarke conducts research combining molecular, clinical, and population-based approaches to address etiology, prevention, and early detection of anogenital, cervical, and endometrial cancers.

G

  • Gadalla, Shahinaz M., Ph.D., M.B.Bch.
    Dr. Gadalla’s research interests focus on identifying and characterizing individuals at high risk of developing cancer and discovering predictive and prognostic biomarkers that may guide therapeutic decisions for those patients.
  • Goldstein, Alisa M., Ph.D.
    Genetic epidemiology of cancer, integrating epidemiologic, clinical, and molecular approaches. Developing and evaluating methods to examine gene-environment interactions in complex diseases.

K

  • Khincha, Payal P., MBBS, MSHS
    Clinical evaluations and genetics epidemiology of individuals with Li-Fraumeni Syndrome. Diagnostic methods and clinical management of dyskeratosis congenita (DC), a cancer-prone inherited bone marrow failure syndrome and telomere biology disorder (TBD).

M

  • McReynolds, Lisa J., M.D., Ph.D.
    Inherited predisposition to hematopoietic malignancies, investigating both germline and somatic mutations effect on disease and transplant outcomes.
  • Mirabello, Lisa, Ph.D.
    Osteosarcoma etiology and risk factors and carcinogenic HPV genomics

S

  • Sargen, Michael R., M.D.
    Studies the clinical, histopathologic, and genetic characteristics of melanoma-prone families. Also uses epidemiologic and molecular approaches to investigate risk factors for sebaceous carcinoma and other rare cutaneous malignancies.
  • Savage, Sharon A., M.D.
    Genetic and molecular epidemiology of telomere biology, pediatric cancer etiology, and inherited cancer predisposition syndromes.
  • Schiffman, Mark H., M.D., M.P.H.
    Molecular epidemiology to study the natural history of human papillomavirus infection on the risk of cervical cancer. Applications for cervical cancer prevention.
  • Stewart, Douglas R., M.D.
    Cancer risk and phenotype in the DICER1 syndrome and neurofibromatosis type 1. Gene identification in familial tumor-predisposition disorders.